Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol.
暂无分享,去创建一个
J J Schentag | W J Jusko | J W Vance | J R Koup | Jerome J. Schentag | M J Gardner | W. Jusko | M. Gardner | A. Mangione | J. Koup | J. Vance | A Mangione
[1] A. Conney. Pharmacological implications of microsomal enzyme induction. , 1967, Pharmacological reviews.
[2] R. Ogilvie,et al. Rational intravenous doses of theophylline. , 1973, The New England journal of medicine.
[3] Sack Rb. Letter: Serotyping of E. coli. , 1976, Lancet.
[4] A K Jain. Cigarette smoking, use of oral contraceptives, and myocardial infarction. , 1976, American journal of obstetrics and gynecology.
[5] C. Shively,et al. Altered plasma half‐lives of antipyrine, propylthiouracil, and methimazole in thyroid dysfunction , 1975, Clinical pharmacology and therapeutics.
[6] R. Ogilvie,et al. Effect of phenobarbital on the disposition of intravenous theophylline , 1977, Clinical pharmacology and therapeutics.
[7] M. Weinberger,et al. Dose-dependent kinetics of theophylline disposition in asthmatic children. , 1977, The Journal of pediatrics.
[8] T. J. White,et al. The liver in congestive heart failure. , 1955, American heart journal.
[9] J J Schentag,et al. Intravenous theophylline therapy: nomogram guidelines. , 1977, Annals of internal medicine.
[10] W. Jusko,et al. Theophylline secretion into breast milk. , 1976, Pediatrics.
[11] W. Jusko,et al. High-pressure liquid chromatographic and spectrophotometric assays for theophylline in biological fluids. , 1976, American journal of hospital pharmacy.
[12] G. Levy,et al. Relationship between theophylline concentration in plasma and saliva of man , 1974, Clinical pharmacology and therapeutics.
[13] L. Sheiner,et al. Modelling of individual pharmacokinetics for computer-aided drug dosage. , 1972, Computers and biomedical research, an international journal.
[14] R. Branch,et al. Effects of an oral contraceptive on hepatic size and antipyrine metabolism in premenopausal women , 1978, Clinical pharmacology and therapeutics.
[15] E. Mezey. Ethanol metabolism and ethanol-drug interactions. , 1976, Biochemical pharmacology.
[16] G. Levy,et al. Pharmacokinetics of theophylline in children with asthma. , 1976, Pediatrics.
[17] M. Kristensen,et al. Rapid evaluation of creatinine clearance. , 1971, Acta medica Scandinavica.
[18] W. Jusko,et al. Effect of smoking on theophylline disposition , 1976, Clinical pharmacology and therapeutics.
[19] J J Schentag,et al. System for clinical pharmacokinetic monitoring of theophylline therapy. , 1976, American journal of hospital pharmacy.
[20] S. Lohmann,et al. Theophylline metabolism by the rat liver microsomal system. , 1976, The Journal of pharmacology and experimental therapeutics.
[21] F. C. Goble. Sex as a factor in metabolism, toxicity, and efficacy of pharmacodynamic and chemotherapeutic agents. , 1975, Advances in pharmacology and chemotherapy.
[22] R. Ogilvie. Clinical Pharmacokinetics of Theophylline , 1978, Clinical pharmacokinetics.
[23] H. T. Howat,et al. Rapid evaluation of creatinine clearance. , 1971, Lancet.
[24] A. Conney,et al. Effect of charcoal‐broiled beef on antipyrine and theophylline metabolism , 1978, Clinical pharmacology and therapeutics.
[25] W. Jusko,et al. Theophylline pharmacokinetics in premature infants with apnea. , 1976, The Journal of pediatrics.
[26] B. Franklin,et al. Theophylline disposition in obesity , 1978, Clinical pharmacology and therapeutics.
[27] S. A. Kaplan. Clinical Pharmacokinetics: A Symposium , 1975 .
[28] R. Senior,et al. Clinical experience with theophylline. Relarionships between dosage, serum concentration, and toxicity. , 1976, JAMA.
[29] H. Nagasawa,et al. Decreased theophylline half-life in cigarette smokers. , 1975, Life sciences.
[30] R. Ogilvie,et al. Pharmacokinetics of intravenous theophylline , 1973, Clinical pharmacology and therapeutics.
[31] D. Hudgel,et al. Inhibition of theophylline clearance by troleandomycin. , 1977, The Journal of allergy and clinical immunology.
[32] R. Ogilvie,et al. Theophylline kinetics in acute pulmonary edema , 1977, Clinical pharmacology and therapeutics.
[33] J. Jenne,et al. Pharmacokinetics of theophylline; Application to adjustment of the clinical dose of aminophylline , 1972, Clinical pharmacology and therapeutics.
[34] J. Schack,et al. An ultraviolet spectrophotometric method for the determination of theophylline and theobromine in blood and tissues. , 1949, The Journal of pharmacology and experimental therapeutics.
[35] V. Beral. MORTALITY AMONG ORAL-CONTRACEPTIVE USERS Royal College of General Practitioners' Oral Contraception Study , 1977, The Lancet.
[36] L. Sheiner,et al. Computer-assisted digoxin therapy. , 1973, The New England journal of medicine.
[37] J. Koch-weser. Drug therapy. Serum drug concentrations as therapeutic guides. , 1972, The New England journal of medicine.
[38] K. Diem. Documenta Geigy Scientific Tables , 1970 .
[39] T. D. Bell,et al. ALTERED THEOPHYLLINE PHARMACOKINETICS DURING ACUTE RESPIRATORY VIRAL ILLNESS , 1978, The Lancet.
[40] J. F. Cumming,et al. The effect of arterial oxygen tension on antipyrine half‐time in plasma , 1976, Clinical pharmacology and therapeutics.
[41] C. Mitoma,et al. The effect of caffeine on drug metabolism. , 1968, Life sciences.
[42] B. Dvorchik,et al. Studies on theobromine disposition in normal subjects; Alterations induced by dietary abstention from or exposure to methylxanthines , 1978, Clinical pharmacology and therapeutics.
[43] R. Ogilvie,et al. Theophylline disposition in patients with hepatic cirrhosis. , 1977, The New England journal of medicine.
[44] C. Lieber. Hepatic and metabolic effects of alcohol (1966 to 1973). , 1973, Gastroenterology.
[45] R. Matthay,et al. Intravenous aminophylline dosage. Use of serum theophylline measurement for guidance. , 1976, JAMA.
[46] Jerome J. Schentag,et al. Enhanced biotransformation of theophylline in marihuana and tobacco smokers , 1978, Clinical pharmacology and therapeutics.
[47] G. Wilkinson,et al. Effects of alteration of hepatic microsomal enzyme activity on liver blood flow in the rat. , 1976, Biochemical pharmacology.
[48] U. Klotz,et al. The effects of age and liver disease on the disposition and elimination of diazepam in adult man. , 1975, The Journal of clinical investigation.
[49] P. Kozak,et al. Administration of erythromycin to patients on theophylline. , 1977, The Journal of allergy and clinical immunology.
[50] E. Middleton,et al. 152. The pharmacokinetics of theophylline in pregnancy , 1978 .
[51] R. Ogilvie,et al. Pharmacokinetic analysis of the disposition of intravenous theophylline in young children. , 1976, The Journal of pediatrics.
[52] H. Nagasawa,et al. Relationship of urinary metabolites of theophylline to serum theophylline levels , 1976, Clinical pharmacology and therapeutics.
[53] L. Hendeles,et al. Absolute bioavailability of oral theophylline. , 1977, American journal of hospital pharmacy.
[54] T. Bell,et al. Variation in theophylline clearance rate with time in chronic childhood asthma. , 1977, The Journal of allergy and clinical immunology.
[55] J. Hull. The Effect of Disease States on Drug Pharmacokinetics , 1977 .
[56] M. Dam,et al. PHENYTOIN and PHENOBARBITONE PLASMA CLEARANCE DURING PREGNANCY , 1976, Acta neurologica Scandinavica.
[57] W. Jusko,et al. Pharmacokinetics of theophylline in hepatic disease. , 1978, Chest.
[58] J. Crooks,et al. Effect of Age and Sex on Human Drug Metabolism , 1971, British medical journal.
[59] S. Schenker,et al. The liver in congestive heart failure: a review. , 1973, The American journal of the medical sciences.
[60] A. Conney,et al. Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man , 1976, Clinical pharmacology and therapeutics.
[61] M. A. González,et al. Effect of phenobarbital on theophylline disposition. , 1978, The Journal of allergy and clinical immunology.
[62] A H Neims,et al. Pharmacokinetic aspects of theophylline in premature newborns. , 1976, The New England journal of medicine.
[63] W. Jusko,et al. Digoxin pharmacokinetics: Role of renal failure in dosage regimen design , 1975, Clinical pharmacology and therapeutics.
[64] N. Draper,et al. Applied Regression Analysis , 1966 .